Literature DB >> 28488973

A pathogen reduction clinical trial in retrospect.

Paolo Rebulla1.   

Abstract

Mesh：

Year:  2017        PMID： 28488973      PMCID： PMC5490728          DOI： 10.2450/2017.0340-16

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  8 in total

1.  The costs of conducting clinical research.

Authors:  Ezekiel J Emanuel; Lowell E Schnipper; Deborah Y Kamin; Jenifer Levinson; Allen S Lichter
Journal:  J Clin Oncol       Date:  2003-10-14       Impact factor: 44.544

2.  Methods for the analysis of bleeding outcomes in randomized trials of PLT transfusion triggers.

Authors:  R J Cook; N M Heddle; P Rebulla; C S Sigouin; K E Webert
Journal:  Transfusion       Date:  2004-08       Impact factor: 3.157

3.  Clinical trials evaluating pathogen-reduced platelet products: methodologic issues and recommendations.

Authors:  Richard J Cook; Nancy M Heddle
Journal:  Transfusion       Date:  2012-11-12       Impact factor: 3.157

4.  Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.

Authors:  Hannes Wandt; Kerstin Schaefer-Eckart; Knut Wendelin; Bettina Pilz; Martin Wilhelm; Markus Thalheimer; Ulrich Mahlknecht; Anthony Ho; Markus Schaich; Michael Kramer; Martin Kaufmann; Lothar Leimer; Rainer Schwerdtfeger; Roland Conradi; Gottfried Dölken; Anne Klenner; Mathias Hänel; Regina Herbst; Christian Junghanss; Gerhard Ehninger
Journal:  Lancet       Date:  2012-08-08       Impact factor: 79.321

5.  Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis.

Authors:  Simon J Stanworth; Cara L Hudson; Lise J Estcourt; Rachel J Johnson; Erica M Wood
Journal:  Haematologica       Date:  2015-03-20       Impact factor: 9.941

6.  Dose of prophylactic platelet transfusions and prevention of hemorrhage.

Authors:  Sherrill J Slichter; Richard M Kaufman; Susan F Assmann; Jeffrey McCullough; Darrell J Triulzi; Ronald G Strauss; Terry B Gernsheimer; Paul M Ness; Mark E Brecher; Cassandra D Josephson; Barbara A Konkle; Robert D Woodson; Thomas L Ortel; Christopher D Hillyer; Donna L Skerrett; Keith R McCrae; Steven R Sloan; Lynne Uhl; James N George; Victor M Aquino; Catherine S Manno; Janice G McFarland; John R Hess; Cindy Leissinger; Suzanne Granger
Journal:  N Engl J Med       Date:  2010-02-18       Impact factor: 91.245

7.  A no-prophylaxis platelet-transfusion strategy for hematologic cancers.

Authors:  Simon J Stanworth; Lise J Estcourt; Gillian Powter; Brennan C Kahan; Claire Dyer; Louise Choo; Lekha Bakrania; Charlotte Llewelyn; Timothy Littlewood; Richard Soutar; Derek Norfolk; Adrian Copplestone; Neil Smith; Paul Kerr; Gail Jones; Kavita Raj; David A Westerman; Jeffrey Szer; Nicholas Jackson; Peter G Bardy; Dianne Plews; Simon Lyons; Linley Bielby; Erica M Wood; Michael F Murphy
Journal:  N Engl J Med       Date:  2013-05-09       Impact factor: 91.245

8.  Improving the reporting of pragmatic trials: an extension of the CONSORT statement.

Authors:  Merrick Zwarenstein; Shaun Treweek; Joel J Gagnier; Douglas G Altman; Sean Tunis; Brian Haynes; Andrew D Oxman; David Moher
Journal:  BMJ       Date:  2008-11-11
  8 in total
  2 in total

1.  Economic Analyses of Pathogen-Reduction Technologies in Blood Transfusion: A Systematic Literature Review.

Authors:  Patrick R LaFontaine; Jing Yuan; Katherine M Prioli; Priti Shah; Jay H Herman; Laura T Pizzi
Journal:  Appl Health Econ Health Policy       Date:  2021-02-08       Impact factor: 2.561

2.  Budget impact of implementing platelet pathogen reduction into the Italian blood transfusion system.

Authors:  Americo Cicchetti; Silvia Coretti; Francesco Sacco; Paolo Rebulla; Alessandra Fiore; Filippo Rumi; Rossella Di Bidino; Luz I Urbina; Pietro Refolo; Dario Sacchini; Antonio G Spagnolo; Emanuela Midolo; Giuseppe Marano; Blandina Farina; Ilaria Pati; Eva Veropalumbo; Simonetta Pupella; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2018-09-03       Impact factor: 3.443
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.